These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6431300)

  • 1. Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites.
    Kamps MP; Taylor SS; Sefton BM
    Nature; 1984 Aug 16-22; 310(5978):589-92. PubMed ID: 6431300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neither arginine nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src.
    Kamps MP; Sefton BM
    Mol Cell Biol; 1986 Mar; 6(3):751-7. PubMed ID: 2430174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of p60src kinase activity in the induction of neuroretinal cell proliferation by rous sarcoma virus.
    Poirier F; Calothy G; Karess RE; Erikson E; Hanafusa H
    J Virol; 1982 Jun; 42(3):780-9. PubMed ID: 6284995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation at the ATP-binding site of pp60v-src abolishes kinase activity, transformation, and tumorigenicity.
    Snyder MA; Bishop JM; McGrath JP; Levinson AD
    Mol Cell Biol; 1985 Jul; 5(7):1772-9. PubMed ID: 3927152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation and metabolism of the transforming protein of Rous sarcoma virus.
    Sefton BM; Patschinsky T; Berdot C; Hunter T; Elliott T
    J Virol; 1982 Mar; 41(3):813-20. PubMed ID: 6178840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiserum specific for the carboxy terminus of the transforming protein of Rous sarcoma virus.
    Sefton BM; Walter G
    J Virol; 1982 Nov; 44(2):467-74. PubMed ID: 6292511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein.
    Schultz AM; Henderson LE; Oroszlan S; Garber EA; Hanafusa H
    Science; 1985 Jan; 227(4685):427-9. PubMed ID: 3917576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An N-terminal peptide from p60src can direct myristylation and plasma membrane localization when fused to heterologous proteins.
    Pellman D; Garber EA; Cross FR; Hanafusa H
    Nature; 1985 Mar 28-Apr 3; 314(6009):374-7. PubMed ID: 3920530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity.
    Buss JE; Kamps MP; Gould K; Sefton BM
    J Virol; 1986 May; 58(2):468-74. PubMed ID: 3009860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1.
    Uehara Y; Murakami Y; Sugimoto Y; Mizuno S
    Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation.
    Kamps MP; Buss JE; Sefton BM
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4625-8. PubMed ID: 2991884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunofluorescent localization of the transforming protein of Rous sarcoma virus with antibodies against a synthetic src peptide.
    Nigg EA; Sefton BM; Hunter T; Walter G; Singer SJ
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5322-6. PubMed ID: 6291037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the ATP-binding site of oncogene products, the epidermal growth factor receptor and related proteins.
    Sternberg MJ; Taylor WR
    FEBS Lett; 1984 Oct; 175(2):387-92. PubMed ID: 6090218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-tyrosine kinases.
    Hunter T; Cooper JA
    Annu Rev Biochem; 1985; 54():897-930. PubMed ID: 2992362
    [No Abstract]   [Full Text] [Related]  

  • 16. High affinity binding of an N-terminal myristoylated p60src peptide.
    Goddard C; Arnold ST; Felsted RL
    J Biol Chem; 1989 Sep; 264(26):15173-6. PubMed ID: 2504718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity labeling of the ATP-binding site of type II calmodulin-dependent protein kinase by 5'-p-fluorosulfonylbenzoyl adenosine.
    King MM; Shell DJ; Kwiatkowski AP
    Arch Biochem Biophys; 1988 Dec; 267(2):467-73. PubMed ID: 2850765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the catalytic subunit of an oligomeric casein kinase (G type). Affinity labeling of the nucleotide site using 5'-[p-(fluorosulfonyl)benzoyl]adenosine.
    Feige JJ; Cochet C; Pirollet F; Chambaz EM
    Biochemistry; 1983 Mar; 22(6):1452-9. PubMed ID: 6573204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity labeling of cAMP-dependent protein kinases.
    Taylor SS; Kerlavage AR; Zoller MJ
    Methods Enzymol; 1983; 99():140-53. PubMed ID: 6316084
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenosine cyclic 3',5'-monophosphate dependent protein kinase: nucleotide binding to the chemically modified catalytic subunit.
    Bhatnagar D; Hartl FT; Roskoski R; Lessor RA; Leonard NJ
    Biochemistry; 1984 Sep; 23(19):4350-7. PubMed ID: 6487604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.